Physician profile
Lance E Jackson
NPI 1174554521
$2,389.76
in general payments reported to CMS, 2019-2025
16 companies · $402 in 2025
The $402 reported for 2025 was less than what a typical Otology & Neurotology provider received nationally (typical 2025 total: $411).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $782 · 2020: $193 · 2021: $275 · 2022: $242 · 2023: $249 · 2024: $247 · 2025: $402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $898.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $898.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $723.54 | 2019-2023 | Senza |
| Advanced Bionics, LLC | $436.20 | 2021-2025 | Hires Ultra Ci Hifocus Ms Electrode |
| Cochlear Americas | $325.85 | 2019-2025 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Medtronic, INC. | $242.46 | 2024-2025 | Propel, Sinuva, Stealthstation S8 Platform |
| Pacira Pharmaceuticals Incorporated | $149.46 | 2019 | |
| Vertiflex, INC. | $124.99 | 2019 | |
| Iotamotion, INC. | $103.48 | 2025 | Iotasoft |
| Agiliti Surgical, INC. | $84.34 | 2020 | |
| Stryker Corporation | $76.04 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $27.95 | 2019 | |
| Smith+Nephew, INC. | $21.53 | 2024 | Tula |
| Otsuka America Pharmaceutical, INC. | $20.18 | 2025 | Rexulti |
| Acclarent, INC | $15.71 | 2022 | |
| Med-El Corporation | $13.91 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.84 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hill Dermaceuticals, INC. | $11.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.